J.P. Morgan Private Wealth Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-726
| Closed | -$187K | – | 1967 |
|
|
2021
Q2 | $187K | Sell |
726
-14
| -2% | -$3.61K | ﹤0.01% | 1847 |
|
|
2021
Q1 | $222K | Sell |
740
-33
| -4% | -$9.9K | ﹤0.01% | 1643 |
|
|
2020
Q4 | $197K | Sell |
773
-182
| -19% | -$46.4K | ﹤0.01% | 1651 |
|
|
2020
Q3 | $238K | Buy |
955
+12
| +1% | +$2.99K | ﹤0.01% | 1460 |
|
|
2020
Q2 | $327K | Sell |
943
-26
| -3% | -$9.02K | ﹤0.01% | 1274 |
|
|
2020
Q1 | $259K | Buy |
969
+207
| +27% | +$55.3K | ﹤0.01% | 1186 |
|
|
2019
Q4 | $247K | Sell |
762
-135
| -15% | -$43.8K | ﹤0.01% | 1318 |
|
|
2019
Q3 | $245K | Sell |
897
-67
| -7% | -$18.3K | ﹤0.01% | 1262 |
|
|
2019
Q2 | $514K | Buy |
964
+9
| +0.9% | +$4.8K | ﹤0.01% | 977 |
|
|
2019
Q1 | $481K | Buy |
955
+17
| +2% | +$8.56K | ﹤0.01% | 1052 |
|
|
2018
Q4 | $462K | Sell |
938
-211
| -18% | -$104K | ﹤0.01% | 998 |
|
|
2018
Q3 | $1.05M | Buy |
1,149
+108
| +10% | +$98.8K | 0.01% | 813 |
|
|
2018
Q2 | $763K | Buy |
1,041
+168
| +19% | +$123K | ﹤0.01% | 862 |
|
|
2018
Q1 | $1.39M | Sell |
873
-533
| -38% | -$849K | 0.01% | 570 |
|
|
2017
Q4 | $1.26M | Sell |
1,406
-318
| -18% | -$285K | 0.01% | 598 |
|
|
2017
Q3 | $620K | Buy |
1,724
+329
| +24% | +$118K | ﹤0.01% | 777 |
|
|
2017
Q2 | $409K | Buy |
1,395
+139
| +11% | +$40.8K | ﹤0.01% | 901 |
|
|
2017
Q1 | $442K | Buy |
+1,256
| New | +$442K | ﹤0.01% | 906 |
|
|
2016
Q3 | – | Sell |
-721
| Closed | -$154K | – | 1257 |
|
|
2016
Q2 | $154K | Buy |
+721
| New | +$154K | ﹤0.01% | 1183 |
|